Hepatitis Monthly

Published by: Kowsar

Effect of Hepatitis B Virus Genotypes on the Efficacy of Adefovir Dipivoxil Antiviral Therapy

Zhili Wen 1 , * , Haiming Zhang 1 , Meiying Zhang 2 , Deming Tan 3 , Qinghua Li 4 , Hua Zhang 1 , Ping Wu 1 and Le Deng 1
Authors Information
1 Department of Hepatology, Infectious Disease Hospital of Nanchang University, Jiangxi, China
2 Department of Medicine, Hospital of Nanchang University, Nanchang, Jiangxi, China
3 Department of Infectious Disease, Xiangya Hospital of Central South University, Changsha, Hunan, China
4 Department of Medicine, People’s Liberation Army Hospital 163, Changsha, Hunan, China
Article information
  • Hepatitis Monthly: August 01, 2014, 14 (8); e10813
  • Published Online: August 17, 2014
  • Article Type: Research Article
  • Received: February 18, 2013
  • Revised: July 7, 2014
  • Accepted: July 22, 2014
  • DOI: 10.5812/hepatmon.10813

To Cite: Wen Z, Zhang H, Zhang M, Tan D, Li Q, et al. Effect of Hepatitis B Virus Genotypes on the Efficacy of Adefovir Dipivoxil Antiviral Therapy, Hepat Mon. 2014 ; 14(8):e10813. doi: 10.5812/hepatmon.10813.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
Acknowledgements
Footnotes
References
  • 1. Chinese Society of H, Chinese Society of Infectious Diseases CMA. [The guideline of prevention and treatment for chronic hepatitis B (2010 version)]. Zhonghua Gan Zang Bing Za Zhi. 2011; 19(1): 13-24[DOI][PubMed]
  • 2. Hou J, Schilling R, Janssen HL, Hansen BE, Heijtink R, Sablon E, et al. Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance. J Med Virol. 2007; 79(8): 1055-63[DOI][PubMed]
  • 3. Jardi R, Rodriguez-Frias F, Schaper M, Giggi E, Tabernero D, Homs M, et al. Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy. J Hepatol. 2008; 49(5): 695-701[DOI][PubMed]
  • 4. Liu CJ, Kao JH. Genetic variability of hepatitis B virus and response to antiviral therapy. Antivir Ther. 2008; 13(5): 613-24[PubMed]
  • 5. Palumbo E. Hepatitis B genotypes and response to antiviral therapy: a review. Am J Ther. 2007; 14(3): 306-9[DOI][PubMed]
  • 6. Enomoto M, Tamori A, Nishiguchi S. Hepatitis B virus genotypes and response to antiviral therapy. Clin Lab. 2006; 52(1-2): 43-7[PubMed]
  • 7. Wen ZL, Tan DM. Detection for genotypes of hepatitis B virus in Hunan Province of China by nested PCR with multiplex pairs of primers. World Chin J Digestology. 2004; 12(2): 332-5
  • 8. Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol. 2001; 39(1): 362-4[DOI][PubMed]
  • 9. Chinese Society of Hepatology CMA, Chinese Society of Infectious Diseases CMA. [The guidelines of prevention and treatment for chronic hepatitis B]. Zhonghua Gan Zang Bing Za Zhi. 2005; 13(12): 881-91[PubMed]
  • 10. Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, et al. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat. 2005; 12(6): 609-17[DOI][PubMed]
  • 11. Wen ZL, Deng Q, Zhang H, Wu P, Zhang HM. Detection for genotypes of hepatitis B virus in Jiangxi Province of China by nested PCR with multiplex pairs of primers and its clinical relevance. Chin J Microbiol Immunol. 2009; 29(2): 175-6
  • 12. Flink HJ, van Zonneveld M, Hansen BE, de Man RA, Schalm SW, Janssen HL, et al. Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype. Am J Gastroenterol. 2006; 101(2): 297-303[DOI][PubMed]
  • 13. Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, et al. Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology. 2008; 135(2): 459-67[DOI][PubMed]
  • 14. Wiegand J, Hasenclever D, Tillmann HL. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence. Antivir Ther. 2008; 13(2): 211-20[PubMed]
  • 15. Hepatology. : 700A-1A
  • 16. Fung SK, Chae HB, Fontana RJ, Conjeevaram H, Marrero J, Oberhelman K, et al. Virologic response and resistance to adefovir in patients with chronic hepatitis B. J Hepatol. 2006; 44(2): 283-90[DOI][PubMed]
  • 17. Zeng AZ, Deng H, Yang C, Xin XJ, Li QL, Guo JJ, et al. Hepatitis B virus genotype-associated variability in antiviral response to adefovir dipivoxil therapy in Chinese Han population. Tohoku J Exp Med. 2008; 216(3): 205-11[PubMed]
  • 18. Zhao H, Li J, Zhang YX, Chen XY, Wang L, Tang XP, et al. [Efficacy of adefovir dipivoxil was not related to genotypes B and C of hepatitis B virus: a randomized, double-blind, multicenter clinical study]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007; 21(3): 282-4[PubMed]
  • 19. Zhang H, Wen ZL, Xiang TX. Detection for genotypes of hepatitis B virus in Jiangxi Province of China by nested PCR with multiplex pairs of primers and its clinical relevance. J Clin Hepatol. 2009; 12(3): 184-6
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments